Serum Cholesterol and Nigrostriatal R2* Values in Parkinson's Disease

作者: Guangwei Du , Mechelle M. Lewis , Michele L. Shaffer , Honglei Chen , Qing X. Yang

DOI: 10.1371/JOURNAL.PONE.0035397

关键词:

摘要: BACKGROUND The occurrence of Parkinson's disease (PD) is known to be associated both with increased nigrostriatal iron content and low serum cholesterol PD, but there has been no study determine a potential relationship between these two factors. METHODS High-resolution MRI (T1-, T2, multiple echo T2*-weighted imaging) fasting lipid levels were obtained from 40 patients PD 29 healthy controls. Iron was estimated mean R2* values (R2* = 1/T2*) calculated for each structure including substantia nigra, caudate, putamen, globus pallidus. This correlated after controlling age, gender, statin use. RESULTS In higher lower in the nigra (R -0.43, p 0.011 total-cholesterol, R -0.31, 0.080 low-density lipoprotein) pallidus -0.38, 0.028 -0.27, 0.127 lipoprotein), only trend toward significant association total-cholesterol striatum -0.34, 0.052 caudate; -0.32, 0.061 putamen). After adjusting clinical measures, cholesterol-iron relationships held or became even stronger pallidus, weaker caudate putamen. There CONCLUSIONS data show that concentration patients. Further studies should investigate whether this mechanistic epiphenomenological relationship.

参考文章(58)
Stanisław J Czuczwar, Karolina Stepień, Michał Tomaszewski, Neuroprotective properties of statins. Pharmacological Reports. ,vol. 57, pp. 561- 569 ,(2005)
Susan J. Hayflick, Manju A. Kurian, Penelope Hogarth, Neurodegeneration with brain iron accumulation Folia Neuropathologica. ,vol. 43, pp. 293- 305 ,(2005) , 10.1016/B978-0-444-63233-3.00019-1
Bing Zhou, Shawn K. Westaway, Barbara Levinson, Monique A. Johnson, Jane Gitschier, Susan J. Hayflick, A novel pantothenate kinase gene ( PANK2 ) is defective in Hallervorden-Spatz syndrome Nature Genetics. ,vol. 28, pp. 345- 349 ,(2001) , 10.1038/NG572
Timothy LaVaute, Sophia Smith, Sharon Cooperman, Kazuhiro Iwai, William Land, Esther Meyron-Holtz, Steven K. Drake, Georgina Miller, Mones Abu-Asab, Maria Tsokos, Robert Switzer, Alexander Grinberg, Paul Love, Nancy Tresser, Tracey A. Rouault, Targeted deletion of the gene encoding iron regulatory protein-2 causes misregulation of iron metabolism and neurodegenerative disease in mice. Nature Genetics. ,vol. 27, pp. 209- 214 ,(2001) , 10.1038/84859
Andrew R.J. Curtis, Constanze Fey, Christopher M Morris, Laurence A. Bindoff, Paul G. Ince, Patrick F. Chinnery, Alan Coulthard, Margaret J. Jackson, Andrew P. Jackson, Duncan P. McHale, David Hay, William A. Barker, Alex F. Markham, David Bates, Ann Curtis, John Burn, Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nature Genetics. ,vol. 28, pp. 350- 354 ,(2001) , 10.1038/NG571
Christian Denk, Alexander Rauscher, Susceptibility weighted imaging with multiple echoes. Journal of Magnetic Resonance Imaging. ,vol. 31, pp. 185- 191 ,(2010) , 10.1002/JMRI.21995
Sandro Altamura, Martina U. Muckenthaler, Iron toxicity in diseases of aging: Alzheimer's disease, Parkinson's disease and atherosclerosis. Journal of Alzheimer's Disease. ,vol. 16, pp. 879- 895 ,(2009) , 10.3233/JAD-2009-1010
Luigi Zecca, Moussa B. H. Youdim, Peter Riederer, James R. Connor, Robert R. Crichton, Iron, brain ageing and neurodegenerative disorders Nature Reviews Neuroscience. ,vol. 5, pp. 863- 873 ,(2004) , 10.1038/NRN1537
D. B. Calne, B. J. Snow, C. Lee, Criteria for diagnosing Parkinson's disease. Annals of Neurology. ,vol. 32, ,(1992) , 10.1002/ANA.410320721